|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5-6
|
|
pubmed:dateCreated |
2006-12-27
|
|
pubmed:abstractText |
It has been suggested that hemodiafiltration (HDF) is more efficient than hemodialysis (HD) in lowering plasma levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA), which is a strong and independent predictor of overall mortality in ESRD patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0253-5068
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
439-44
|
|
pubmed:meshHeading |
pubmed-meshheading:16940714-Adult,
pubmed-meshheading:16940714-Aged,
pubmed-meshheading:16940714-Arginine,
pubmed-meshheading:16940714-Female,
pubmed-meshheading:16940714-Hemodiafiltration,
pubmed-meshheading:16940714-Humans,
pubmed-meshheading:16940714-Kidney Failure, Chronic,
pubmed-meshheading:16940714-Male,
pubmed-meshheading:16940714-Middle Aged,
pubmed-meshheading:16940714-Nitric Oxide,
pubmed-meshheading:16940714-Nitric Oxide Synthase,
pubmed-meshheading:16940714-beta 2-Microglobulin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients.
|
|
pubmed:affiliation |
Institute of Clinical Chemistry and Laboratory Diagnostics,Charles University and General University Hospital, Prague, Czech Republic.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
